December 6, 2016
December 6, 2016 —
Patients at the newly opened Jacobs Medical Center at UC San Diego Health can be in command of their own experience by controlling room temperature, lighting, accessing their personal medical information, details on their patient care team and entertainment options all from their beds.
December 1, 2016
December 1, 2016 —
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings could have a clinical role in improving efficiency of immunotherapy drugs.
November 15, 2016
November 15, 2016 —
A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease, a result that may reveal new therapeutic targets.
November 3, 2016
November 3, 2016 —
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of obesity and diabetes.
October 24, 2016
October 24, 2016 —
There are many unanswered questions about the mechanisms that contribute to the onset of type 1 diabetes. Researchers at University of California San Diego School of Medicine hope to answer some of them with two Type 1 Diabetes Special Statutory Funding Program grants from the National Institutes of Health totaling more than $5 million.
October 4, 2016
October 4, 2016 —
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
September 23, 2016
September 23, 2016 —
A three-part series published in The Lancet and released in conjunction with the United Nations quantifies health gains achieved if cities were designed so that shops, facilities, work and public transportation were within walking distance of most residents. In part three of the series published Sept. 23, 2016, researchers tackle how to implement timely research into city design, planning and policy to improve the health of a city’s residents.
September 20, 2016
September 20, 2016 —
University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.
September 7, 2016
September 7, 2016 —
When 28 distinguished individuals convened earlier this year to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiative, they were given five months to draft guidelines to accelerate cancer research, prevention and care. On Wednesday, the National Cancer Advisory Board approved the Blue Ribbon Panel’s 10 recommendations.
August 2, 2016
August 2, 2016 —
Ranked No. 1 in San Diego, UC San Diego Health and its hospitals have been recognized among the best in the nation by U.S. News & World Report for 2016-17. The annual U.S. News & World Report “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health conditions.
